About LOMITAPIDE
            
            Class: | Lipid-lowering agent, Microsomal triglyceride transfer protein (MTP) inhibitor  
Use: | Treatment of homozygous familial hypercholesterolemia (HoFH) as an adjunct to a low-fat diet and other lipid-lowering therapies  
Adult dose: | 5 mg orally once daily, may be increased to 10 mg after 2 to 4 weeks based on tolerability and response  
Pediatric dose: | Safety and efficacy not established in pediatric patients  
Side effects: | Gastrointestinal symptoms (nausea, diarrhea, abdominal pain
         
        
            
                
                
                    
                        Drug Class
                    
                    Lipid-lowering agent, Microsomal triglyceride transfer protein (MTP) inhibitor
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of homozygous familial hypercholesterolemia (HoFH) as an adjunct to a low-fat diet and other lipid-lowering therapies
                 
                
                
                    
                        Storage Requirements
                    
                    Store at room temperature (20°C to 25°C or 68°F to 77°F); protect from moisture and light
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: AMRYT PHARMACEUTICALS DAC, Ireland
                    
                    
                    Package Size
                    28's
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 117531.68
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        5 mg orally once daily, may be increased to 10 mg after 2 to 4 weeks based on tolerability and response
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established in pediatric patients
                    
                 
                
                
                    
                        Side Effects
                    
                    Gastrointestinal symptoms (nausea, diarrhea, abdominal pain), liver enzyme elevations, fat-soluble vitamin deficiencies
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Active liver disease, pregnancy, breastfeeding, hypersensitivity to lomitapide or any component of the formulation
         
        
        
            
                Important Warnings
            
            Risk of hepatotoxicity; monitor liver function tests before and during treatment; avoid use with strong CYP3A4 inhibitors; may cause gastrointestinal side effects; ensure patients are on a low-fat diet to minimize risk of liver toxicity.
         
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.